Israel
· Delayed Price · Currency is ILS · Price in ILAGencell Statistics
Total Valuation
Gencell has a market cap or net worth of ILS 61.01 million. The enterprise value is -3.27 million.
| Market Cap | 61.01M |
| Enterprise Value | -3.27M |
Important Dates
The next estimated earnings date is Wednesday, November 27, 2024.
| Earnings Date | Nov 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Gencell has 108.18 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Shares Outstanding | 108.18M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 13.39% |
| Owned by Institutions (%) | 17.37% |
| Float | 53.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.48 |
| PB Ratio | 0.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.03 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.04 |
Financial Position
The company has a current ratio of 4.72, with a Debt / Equity ratio of 10.13.
| Current Ratio | 4.72 |
| Quick Ratio | 3.79 |
| Debt / Equity | 10.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -195.87 |
Financial Efficiency
Return on equity (ROE) is -58.78% and return on invested capital (ROIC) is -33.29%.
| Return on Equity (ROE) | -58.78% |
| Return on Assets (ROA) | -28.85% |
| Return on Capital (ROIC) | -33.29% |
| Revenue Per Employee | 125,243 |
| Profits Per Employee | -670,618 |
| Employee Count | 140 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 1.83 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.00% in the last 52 weeks. The beta is 0.71, so Gencell's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -55.00% |
| 50-Day Moving Average | 62.57 |
| 200-Day Moving Average | 94.03 |
| Relative Strength Index (RSI) | 37.05 |
| Average Volume (20 Days) | 166,531 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gencell had revenue of ILS 17.53 million and -93.89 million in losses. Loss per share was -0.87.
| Revenue | 17.53M |
| Gross Profit | -17.55M |
| Operating Income | -95.87M |
| Pretax Income | -93.63M |
| Net Income | -93.89M |
| EBITDA | -94.57M |
| EBIT | -95.87M |
| Loss Per Share | -0.87 |
Balance Sheet
The company has 76.44 million in cash and 12.16 million in debt, giving a net cash position of 64.28 million or 0.59 per share.
| Cash & Cash Equivalents | 76.44M |
| Total Debt | 12.16M |
| Net Cash | 64.28M |
| Net Cash Per Share | 0.59 |
| Equity (Book Value) | 119.99M |
| Book Value Per Share | 1.10 |
| Working Capital | 100.83M |
Cash Flow
In the last 12 months, operating cash flow was -79.32 million and capital expenditures -6.78 million, giving a free cash flow of -86.10 million.
| Operating Cash Flow | -79.32M |
| Capital Expenditures | -6.78M |
| Free Cash Flow | -86.10M |
| FCF Per Share | -0.80 |
Margins
| Gross Margin | -100.06% |
| Operating Margin | -546.77% |
| Pretax Margin | -533.99% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -491.07% |
Dividends & Yields
Gencell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.22% |
| Shareholder Yield | -0.22% |
| Earnings Yield | -153.90% |
| FCF Yield | -141.13% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |